13G Filing: Scopia Capital Raises Stake in Insys Therapeutics, Inc. (INSY)

Page 2 of 12

Page 2 of 12 SEC Filing

CUSIP No.
45824V209
1.
NAME OF REPORTING PERSONS:  Scopia Capital Management LP
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
7,434,936
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
7,434,936
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,434,936
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
10.40%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN, IA

Follow Insys Therapeutics Inc. (NASDAQ:INSY)

Page 2 of 12